Overview

A Study to Investigate the Effect of Food With Mirabegron in Healthy Chinese Participants

Status:
Completed
Trial end date:
2020-10-27
Target enrollment:
Participant gender:
Summary
This study determined the effect of food on the pharmacokinetics (PK) of single oral doses of mirabegron in healthy Chinese male and female participants. This study also evaluated the safety and tolerability of single oral doses of mirabegron in healthy Chinese male and female participants.
Phase:
Phase 4
Details
Lead Sponsor:
Astellas Pharma China, Inc.
Treatments:
Mirabegron